English press releases

Phase 3 Clinical Trial Subgroup Analysis Across Solid Organ Transplant (SOT) Types Supports Efficacy of Maribavir Over Conventional Therapies in Post-Transplant Recipients With Cytomegalovirus (CMV) Infection (Refractory, With or Without Resistance)

Building Upon Previous Data Showing More Than Twice as Many SOT Recipients Receiving Maribavir Achieved CMV Viremia Clearance Compared to Conventional Antiviral Therapies, Subgroup Analysis...

TIP harnesses ADVA for successful trial of end-to-end open optical network

News summary: Openness and disaggregation will be key for next-generation infrastructure TIP PoC of unified software-defined network management is major step towards open solutions free...

Samsung’s Semiconductor Sites Awarded Industry’s First ‘Triple Standard’ by Carbon Trust

All of Samsung’s global semiconductor manufacturing facilities certified for reducing carbon emissions, water use and waste discharge SEOUL, South Korea–(BUSINESS WIRE)– Samsung Electronics Co., Ltd.,...

Aegon Annual General Meeting approves all resolutions

THE HAGUE, Netherlands–(BUSINESS WIRE)– Aegon N.V.’s Annual General Meeting of Shareholders (AGM) today approved all resolutions on the agenda. These include adoption of the Annual...

Isotropic Systems and SES GS Complete Milestone Trials to Unlock Next-Gen Connectivity for U.S. Military

Successful multi-beam, over-the-air tests in the UK and US advance multi-beam antenna development LONDON & RESTON, Va.–(BUSINESS WIRE)– SES Government Solutions (SES GS), a wholly-owned...

Groups360 Launches Global Direct Booking Solution for Group Room Blocks with Hilton

Majority of Hilton hotels are integrated with Group360’s GroupSync to offer real-time rates and availability for guest rooms for groups NASHVILLE, Tenn.–(BUSINESS WIRE)– Groups360 and...

beqom Expands Reach into Asia Pacific with Leading Global Investment Services Provider

NYON, Switzerland–(BUSINESS WIRE)– beqom, a cloud-based total compensation software provider, has announced that a leading global investment services firm, headquartered in Australia, has successfully implemented...

Boehringer Ingelheim and Zealand Pharma Receive FDA Fast Track Designation for Investigational Treatment for NASH

FDA’s Fast Track Designation for the GLP-1/glucagon dual agonist underscores the urgent need for new treatment options to fulfill the unmet medical needs of people...

Samsung Introduces its First ZNS SSD with Maximized User Capacity and Enhanced Lifespan

Maximum available storage capacity and 3-4x longer lifespan enable server systems to run big data and AI applications more reliably and efficiently SEOUL, Korea–(BUSINESS WIRE)–...

TSMC Unveils Innovations at 2021 Online Technology Symposium

Debuts N6RF for enhanced 5G smartphone experience, N5A for state-of-the-art automotive, and new 3DFabricTM technologies. HSINCHU, Taiwan–(BUSINESS WIRE)– TSMC (TWSE: 2330, NYSE: TSM) is unveiling...

Ipsen Announces the Launch of an Employee Shareholding Plan

PARIS–(BUSINESS WIRE)– Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty biopharmaceutical group, announces the launch of an Employee Shareholding plan. This third transaction...

BeiGene Announces First Presentation of the Phase 3 ALPINE Trial Comparing BRUKINSA® (Zanubrutinib) to Ibrutinib in Chronic Lymphocytic Leukemia to Be Featured in Presidential Symposium at EHA2021

BRUKINSA demonstrated superior objective response rate by investigator assessment in the planned interim analysis BRUKINSA was associated with a statistically significant lower risk of atrial...

CORCYM: Today the Global Launch

The new medical device company enters the market today with state-of-the-art surgical solutions to fight structural heart disease LONDON–(BUSINESS WIRE)– CORCYM the new, independent, medical...

Monde Nissin Completes Largest IPO in Philippines History and Begins Trading on the PSE

NOT FOR PUBLICATION OR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN AND AUSTRALIA MAKATI CITY, Phillippines–(BUSINESS WIRE)– Monde Nissin Corporation (“Monde Nissin” or the “Company”;...

BridgeBio Pharma’s Affiliate QED Therapeutics and Partner Helsinn Group Announce FDA Approval of TRUSELTIQ™ (infigratinib) for Patients with Cholangiocarcinoma

Pivotal study demonstrated a clinically meaningful rate of tumor shrinkage (overall response rate) and duration of response in patients with previously-treated advanced cholangiocarcinoma (CCA) harboring...